BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32301251)

  • 21. Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy.
    Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
    Am J Hematol; 2017 Mar; 92(3):251-258. PubMed ID: 28006849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.
    Lammers EMJ; Zijlstra JM; Retèl VP; Aleman BMP; van Leeuwen FE; Nijdam A;
    JMIR Res Protoc; 2024 Apr; 13():e55601. PubMed ID: 38635308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany.
    Tilch MK; Galle PR; Schattenberg JM; Kostev K; Labenz C
    Support Care Cancer; 2022 Mar; 30(3):2387-2395. PubMed ID: 34761297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The course of anxiety and depression for patients with Hodgkin's lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry.
    Oerlemans S; Mols F; Nijziel MR; Zijlstra WP; Coebergh JW; van de Poll-Franse LV
    J Cancer Surviv; 2014 Dec; 8(4):555-64. PubMed ID: 24820429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of disability pension for patients diagnosed with haematological malignancies: a register-based cohort study.
    Horsboel TA; Nielsen CV; Andersen NT; Nielsen B; de Thurah A
    Acta Oncol; 2014 Jun; 53(6):724-34. PubMed ID: 24456498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-reported distress in Hodgkin lymphoma across the survivorship continuum.
    Troy JD; Locke SC; Samsa GP; Feliciano J; Richhariya A; LeBlanc TW
    Support Care Cancer; 2019 Jul; 27(7):2453-2462. PubMed ID: 30377801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship.
    Muffly LS; Hlubocky FJ; Khan N; Wroblewski K; Breitenbach K; Gomez J; McNeer JL; Stock W; Daugherty CK
    Cancer; 2016 Mar; 122(6):954-61. PubMed ID: 26749023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fear of cancer recurrence in Non- and Hodgkin lymphoma survivors during their first three years of survivorship among French patients.
    Walburg V; Rueter M; Lamy S; Compaci G; Lapeyre-Mestre M; Laurent G; Despas F
    Psychol Health Med; 2019 Aug; 24(7):781-787. PubMed ID: 30714815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark.
    Chang ET; Frøslev T; Sørensen HT; Pedersen L
    Br J Cancer; 2011 Nov; 105(11):1776-82. PubMed ID: 22027707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients.
    Jensen O; Øvlisen AK; Jakobsen LH; Roug AS; Nielsen RE; Marcher CW; Ebbesen LH; Theilgaard-Mönch K; Møller P; Schöllkopf C; Torp-Pedersen C; El-Galaly TC; Severinsen MT
    Clin Epidemiol; 2022; 14():225-237. PubMed ID: 35241936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.
    Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
    J Cancer Surviv; 2015 Dec; 9(4):599-609. PubMed ID: 25689964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival.
    Tao R; Chen Y; Kim S; Ocier K; Lloyd S; Poppe MM; Lee CJ; Glenn MJ; Smith KR; Fraser A; Deshmukh V; Newman MG; Snyder J; Rowe KG; Gaffney DK; Haaland B; Hashibe M
    Cancer; 2022 Oct; 128(19):3564-3572. PubMed ID: 35916651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan.
    Oeffinger KC; Hudson MM; Mertens AC; Smith SM; Mitby PA; Eshelman-Kent DA; Ford JS; Jones JK; Kamani S; Robison LL
    Pediatr Blood Cancer; 2011 May; 56(5):818-24. PubMed ID: 21370417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
    J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
    Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.
    Rugbjerg K; Maraldo M; Aznar MC; Cutter DJ; Darby SC; Specht L; Olsen JH
    Int J Cancer; 2017 May; 140(10):2232-2245. PubMed ID: 28213927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study.
    Rydén I; Thurin E; Carstam L; Smits A; Gulati S; Henriksson R; Salvesen Ø; Store Jakola A
    BMC Cancer; 2021 Mar; 21(1):248. PubMed ID: 33685410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Race, Ethnicity, and Socioeconomic Status over Time on the Long-term Survival of Adolescent and Young Adult Hodgkin Lymphoma Survivors.
    Berkman AM; Andersen CR; Puthenpura V; Livingston JA; Ahmed S; Cuglievan B; Hildebrandt MAT; Roth ME
    Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1717-1725. PubMed ID: 34244160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.